Adjunctive Intranasal Esketamine in Treatment-Resistant Depression-Reply
JAMA Psychiatry
.
2018 Jun 1;75(6):654-655.
doi: 10.1001/jamapsychiatry.2018.0430.
Authors
Ella J Daly
1
,
Jaskaran B Singh
2
Affiliations
1
Department of Neuroscience, Janssen Research & Development, LLC, Titusville, New Jersey.
2
Department of Neuroscience, Janssen Research & Development, LLC, San Diego, California.
PMID:
29800990
DOI:
10.1001/jamapsychiatry.2018.0430
No abstract available
Publication types
Letter
Comment
MeSH terms
Administration, Intranasal
Antidepressive Agents
Depression
Depressive Disorder, Treatment-Resistant*
Humans
Ketamine*
Substances
Antidepressive Agents
Ketamine